Agilent, Kreatech Ink Labeling Technology Licensing Agreement | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) –Agilent Technologies and Kreatech Diagnostics today announced a licensing and supply agreement for the Dutch molecular diagnostic firm's ULS technology and products, broadening an existing collaboration between the two companies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.